Menu

PHILADELPHIA PHARMACEEUTICALS Financial

Trading Information in the Regular Market

2020 2019 2018
Par Value/Share (JD) 1.00 1.00 1.00
Closing Price (JD) 1.43 1.56 1.58
Value Traded (JD) 76,768 236,030 1,342,858
No. of Shares Traded 55,027 141,709 835,814
No. of Transactions 195 264 657
No. of Subscribed Shares 7,500,000 7,500,000 7,500,000
Market Capitalization (JD) 10,725,000 11,700,000 11,850,000
Fiscal Year Ended 31/12/2020 31/12/2019 31/12/2018

Assets (JD)

2020 2019 2018
Cash on Hand & at Banks 1,602,699 1,232,908 965,365
Notes Receivable 0 0 0
Post Dated Cheques 0 0 0
Short Term Investments 0 0 0
Inventory 1,991,129 1,795,499 1,481,124
Spare Parts 0 0 0
Total Current Assets 12,577,503 13,431,350 11,036,223
Long Term Investments 0 0 0
Fixed Assets, Net 2,258,312 2,412,144 2,466,855
Lands 124,865 124,865 124,865
Projects in Progress 0 0 0
Total Fixed Assets 2,383,177 2,537,009 2,591,720
Other Assets 46,868 63,753 101,734
Total Assets 15,007,548 16,032,112 13,729,677

Liabilities (JD)

2020 2019 2018
Credit Banks 1,647,048 2,163,156 1,386,459
Short Term Loans 0 0 0
Accrued Part of Long Term Loans 0 0 0
Total Current Liabilities 3,556,282 4,347,558 2,943,655
Long Term Loans & Notes Payable 0 0 0
Corporate Bonds 0 0 0
Other Liabilities 0 0 0
Total Liabilities 3,556,282 4,347,558 2,943,655

Shareholders Equity (JD)

2020 2019 2018
Authorized Capital 7,500,000 7,500,000 7,500,000
Subscribed Capital 7,500,000 7,500,000 7,500,000
Paid in Capital 7,500,000 7,500,000 7,500,000
Compulsory Reserves 1,303,595 1,286,923 1,143,970
Voluntary Reserve 266,772 266,772 266,772
Other Reserves 0 0 0
Issuance Premium 0 0 0
Issuance Discount 0 0 0
Treasury Stocks 0 0 0
Cash Dividends 0 375,000 375,000
Stock Dividends 0 0 0
Accumulated Change in Fair Value 0 0 0
Retained Earnings 2,380,899 2,255,859 1,500,280
Total Shareholders Equity 11,451,266 11,684,554 10,786,022
Non-controlling Interest 0 0 0
Total Liabilities & Shareholders Equity 15,007,548 16,032,112 13,729,677

Income Statement (JD)

2020 2019 2018
Operating Revenues 7,655,266 9,114,673 8,000,441
Operating Expenses 4,197,924 4,342,716 4,037,512
Gross Profit 3,457,342 4,771,957 3,962,929
General and Administrative Expenses 906,509 959,701 855,365
Selling and Distribution Expenses 1,908,417 1,883,800 1,612,369
Depreciation (Period) 309,848 372,723 340,230
Other Operating Expenses 180,315 201,843 183,433
Net Operating Income 462,101 1,726,613 1,311,762
Other Revenues 41,767 5,274 3,014
Other Expenses 0 0 0
Income Before Interest & Tax 503,868 1,731,887 1,314,776
Interest Expenses 302,148 267,359 210,973
Net Income Before Tax 201,720 1,464,528 1,103,803
Income Tax (Period) 25,008 156,000 60,246
Income Tax (Previous Years) 0 0 0
Universities and Research Train Fees 0 0 0
Board of Directors Remuniration 35,000 35,000 35,000
Net Income 141,712 1,273,528 1,008,557
Non-controlling Interest 0 0 0
Net Income Pertains to Shareholders 141,712 1,273,528 1,008,557

Cash Flow (JD)

2020 2019 2018
Cash Balance (Beginning) 1,232,908 965,365 579,773
Net Cash Flow from (Used in) Operating Activities 1,702,178 405,598 1,668,236
Net Cash Flow from (Used in) Investing Activities -139,131 -272,393 -382,179
Net Cash Flow from (Used in) Financing Activities -1,193,256 134,338 -900,465
Cash Balance (Ending) 1,602,699 1,232,908 965,365

Financial Ratios

2020 2019 2018
Turnover Ratio % 0.734 1.890 11.144
Earning Per Share (JD) 0.019 0.170 0.135
Dividend Per Share (JD) 0.000 0.050 0.050
Book Value Per Share (JD) 1.527 1.558 1.438
Price Earnings Ratio (Times) 75.682 9.187 11.750
Dividend Yield % 0.000 3.205 3.165
Dividend Per Share to Earning Per Share % 0.000 29.446 37.182
Price to Book Value (Times) 0.937 1.001 1.099
Gross Margin % 45.163 52.355 49.534
Margin Before Interest and Tax % 6.582 19.001 16.434
Profit Margin % 1.851 13.972 12.606
Return On Assets % 0.944 7.944 7.346
Return On Equity % 1.238 10.899 9.351
Debt Ratio % 23.697 27.118 21.440
Equity Ratio % 76.303 72.882 78.560
Interest Coverage Ratio (Times) 1.668 6.478 6.232
Total Assets Turnover (Times) 0.510 0.569 0.583
Fixed Assets Turnover (Times) 3.212 3.593 3.087
Working Capital Turnover (Times) 0.849 1.003 0.989
Current Ratio (Times) 3.537 3.089 3.749
Working Capital (JD) 9,021,221.000 9,083,792.000 8,092,568.000